Real-World Data on Maintenance Avelumab Treatment

The JAVELIN Bladder 100 trial showed a survival benefit for maintenance avelumab following platinum-based chemotherapy in metastatic/locally advanced urothelial carcinoma. This study aimed to provide further insights into real-world outcomes and progression-free survival for patients treated with avelumab, presented in this MEDtalk by Dr. Rehan.